What is the evidence for empagliflozin in HFpEF?

27 August 2022 (12:50 - 13:00)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF? Heart Failure with Preserved Ejection Fraction (HFpEF) Open Access ESC Congress 2022

About the speaker

Photo

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

The Event

Event poster

ESC Congress 2022

27 August 2022 12:50 CET

ESC 365 is supported by

ESC 365 is supported by